185 related articles for article (PubMed ID: 32446833)
1. Development of a live attenuated duck hepatitis A virus type 3 vaccine (strain SD70).
Wu F; Lu F; Fan X; Pan Q; Zhao S; Sun H; Zhang J; Liu C; Chao J; Zhang X
Vaccine; 2020 Jun; 38(30):4695-4703. PubMed ID: 32446833
[TBL] [Abstract][Full Text] [Related]
2. Development of duck hepatitis A virus type 3 vaccine and its use to protect ducklings against infections.
Kim MC; Kim MJ; Kwon YK; Lindberg AM; Joh SJ; Kwon HM; Lee YJ; Kwon JH
Vaccine; 2009 Nov; 27(48):6688-94. PubMed ID: 19747575
[TBL] [Abstract][Full Text] [Related]
3. Protective efficacy of a bivalent live attenuated vaccine against duck hepatitis A virus types 1 and 3 in ducklings.
Kang M; Roh JH; Jang HK
Vet Microbiol; 2018 Feb; 214():108-112. PubMed ID: 29408021
[TBL] [Abstract][Full Text] [Related]
4. Isolation, identification and attenuation of a pathogenic duck hepatitis virus type 1 in China, and complete genomic sequence comparison between the embryo-passaged, attenuated derivatives and their parent.
Liu X; Kong X
Pol J Vet Sci; 2019 Mar; 22(1):163-171. PubMed ID: 30997771
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology of duck hepatitis a virus types 1 and 3 in China, 2010-2015.
Wen X; Zhu D; Cheng A; Wang M; Chen S; Jia R; Liu M; Sun K; Zhao X; Yang Q; Wu Y; Chen X
Transbound Emerg Dis; 2018 Feb; 65(1):10-15. PubMed ID: 29076646
[TBL] [Abstract][Full Text] [Related]
6. [Development and evaluation of an inactivated bivalent vaccine against duck viral hepatitis].
Yin F; Jing L; Zhang S; Yu M; Zhang W; Fan G; Dong X; Liu W
Sheng Wu Gong Cheng Xue Bao; 2015 Nov; 31(11):1579-88. PubMed ID: 26939441
[TBL] [Abstract][Full Text] [Related]
7. Evidence of possible vertical transmission of duck hepatitis A virus type 1 in ducks.
Zhang R; Yang Y; Lan J; Xie Z; Zhang X; Jiang S
Transbound Emerg Dis; 2021 Mar; 68(2):267-275. PubMed ID: 32598568
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis for vaccine protection rate of duck hepatitis a virus in mainland China in 2009-2021.
Ye L; Zhou S; Zhang H; Zhang T; Yang D; Hong X
BMC Vet Res; 2023 Sep; 19(1):179. PubMed ID: 37773135
[TBL] [Abstract][Full Text] [Related]
9. Current status and future direction of duck hepatitis A virus vaccines.
Zhang Y; Wu S; Liu W; Hu Z
Avian Pathol; 2023 Apr; 52(2):89-99. PubMed ID: 36571394
[TBL] [Abstract][Full Text] [Related]
10. Protection of Ducklings from Duck Hepatitis A Virus Infection with ELPylated Duck Interferon-α.
Wang Y; Guo Y; Wang H; Wu Z; Hong W; Sun H; Zhu S
Viruses; 2022 Mar; 14(3):. PubMed ID: 35337040
[TBL] [Abstract][Full Text] [Related]
11. Development of a live attenuated vaccine against Muscovy duck reovirus infection.
Chen S; Lin F; Chen S; Hu Q; Cheng X; Jiang B; Zhu X; Wang S; Zheng M; Huang M
Vaccine; 2018 Dec; 36(52):8001-8007. PubMed ID: 30420117
[TBL] [Abstract][Full Text] [Related]
12. Comparative pathogenicity of different subtypes of duck hepatitis A virus in Pekin ducklings.
Liu R; Shi S; Huang Y; Chen Z; Chen C; Cheng L; Fu G; Chen H; Wan C; Fu Q
Vet Microbiol; 2019 Jan; 228():181-187. PubMed ID: 30593365
[TBL] [Abstract][Full Text] [Related]
13. Live attenuated duck hepatitis virus vaccine in breeder ducks: Protective efficacy and kinetics of maternally derived antibodies.
Roh JH; Kang M
Vet Microbiol; 2018 Jun; 219():107-112. PubMed ID: 29778181
[TBL] [Abstract][Full Text] [Related]
14. The pathogenicity of duck hepatitis A virus types 1 and 3 on ducklings.
Niu Y; Ma H; Ding Y; Li Z; Sun Y; Li M; Shi Y
Poult Sci; 2019 Dec; 98(12):6333-6339. PubMed ID: 31393586
[TBL] [Abstract][Full Text] [Related]
15. Dual Circulation of Duck Hepatitis A Virus Genotypes 1 and 3 in Egypt.
Yehia N; Erfan AM; Omar SE; Soliman MA
Avian Dis; 2021 Mar; 65(1):1-9. PubMed ID: 34339115
[TBL] [Abstract][Full Text] [Related]
16. Effect of fetal calf serum on propagation of duck hepatitis A virus genotype 3 in duck embryo fibroblast cells.
Wang M; Li Z; Liu H; Wang X; Zhang D
BMC Vet Res; 2019 May; 15(1):153. PubMed ID: 31101110
[TBL] [Abstract][Full Text] [Related]
17. Duck hepatitis A virus prevalence in mainland China between 2009 and 2021: A systematic review and meta-analysis.
Zhou S; Li S; Wang Y; Li X; Zhang T
Prev Vet Med; 2022 Nov; 208():105730. PubMed ID: 35964373
[TBL] [Abstract][Full Text] [Related]
18. Comparative pathogenicity of two subtypes (hepatitis-type and pancreatitis-type) of duck hepatitis A virus type 1 in experimentally infected Muscovy ducklings.
Zhu T; Qi B; Liu R; Jiang X; Lu R; Xiao L; Fu G; Fu Q; Shi S; Wan C; Huang Y
Avian Pathol; 2019 Aug; 48(4):352-361. PubMed ID: 30982334
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of duck embryo epithelial (DEE) cell line and its use as a new approach toward DHAV-1 propagation and vaccine development.
Wang W; Said A; Wang Y; Fu Q; Xiao Y; Lv S; Shen Z
Virus Res; 2016 Feb; 213():260-268. PubMed ID: 26739426
[TBL] [Abstract][Full Text] [Related]
20. Development of an attenuated live vaccine candidate of duck Tembusu virus strain.
He D; Zhang X; Chen L; Tang Y; Diao Y
Vet Microbiol; 2019 Apr; 231():218-225. PubMed ID: 30955813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
